(Q44433702)

2 December 2017

Inflammatory cytokines at the summits of pathological signal cascades in brain diseases (English)

1 reference

2 December 2017

0 references

Lawrence Steinman

1

1 reference

2 December 2017

15 January 2013

1 reference

2 December 2017

1 reference

2 December 2017

6

1 reference

2 December 2017

pe3

1 reference

2 December 2017

258

1 reference

Innate and adaptive autoimmunity directed to the central nervous system

2 December 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Interferon-β therapy against EAE is effective only when development of the disease depends on the NLRP3 inflammasome

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Good response to IL-1beta blockade by anakinra in a 23-year-old CINCA/NOMID patient without mutations in the CIAS1 gene. Cytokine profiles and functional studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Optimization of current and future therapy for autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

The discovery of natalizumab, a potent therapeutic for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

T helper type 1 and 17 cells determine efficacy of interferon-beta in multiple sclerosis and experimental encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Interferon-β exacerbates Th17-mediated inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Protective effect of an elastase inhibitor in a neuromyelitis optica-like disease driven by a peptide of myelin oligodendroglial glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Serum IL-17F does not predict poor response to IM IFNβ-1a in relapsing-remitting MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Serum levels of IL-17A in patients with relapsing-remitting multiple sclerosis treated with interferon-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Immune response during interferon beta-1b treatment in patients with multiple sclerosis who experienced relapses and those who were relapse-free in the START study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Excessive biologic response to IFNβ is associated with poor treatment response in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

The vagus nerve and the inflammatory reflex--linking immunity and metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

Lessons learned at the intersection of immunology and neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCISIGNAL.2003898

10.1126/SCISIGNAL.2003898

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference

PubMed ID

23322904